NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aitia

Aitia

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.aitia.com/

Last Round

Series D

Jul 9, 2019

Total Funding Raised

$48M

Company Overview

Aitia is a biotechnology company that leverages causal AI and its proprietary 'Gemini Digital Twins' platform to simulate human disease biology for drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

causal AIdigital twinsdrug discoveryin-silico drug discoveryAI-driven drug discoverytarget identificationdisease modelingbiotech AIprecision medicinecomputational biologyoncology researchneurodegenerative disease researchAI drug pipelinetranslational medicinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aitia Comparables

Compare Aitia with similar companies based on industry and business-model similarity.

Aitia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valo Health
84%
Turbine
82%
Insilico Medicine
81%

Aitia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 9, 2019
VC RoundAug 23, 2017
StrategicMay 23, 2016
Series CDec 8, 2015
Series BJan 29, 2014
Series A
Apr 18, 2012

Aitia Investors

Notable investors and investment history

Aitia investors
InvestorRounds
Cigna VenturesSeries D
GHO CapitalVC Round
Amgen VenturesSeries D, VC Round
Alexandria Venture InvestmentsSeries D
Cigna InvestmentsSeries D
Zambon PharmaceuticalsSeries D, VC Round
Big Red VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 23, 2016

    Horizon BlueCross BlueShield of New Jersey participated in the round.

Aitia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aitia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aitia's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range4
Year Founded2000
Last FundingJul 9, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.